CA2360319A1 - Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes - Google Patents

Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes Download PDF

Info

Publication number
CA2360319A1
CA2360319A1 CA002360319A CA2360319A CA2360319A1 CA 2360319 A1 CA2360319 A1 CA 2360319A1 CA 002360319 A CA002360319 A CA 002360319A CA 2360319 A CA2360319 A CA 2360319A CA 2360319 A1 CA2360319 A1 CA 2360319A1
Authority
CA
Canada
Prior art keywords
bone
resorptive
agent
cement
cement dough
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002360319A
Other languages
English (en)
Inventor
John H. Healey
Gene R. Diresta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2360319A1 publication Critical patent/CA2360319A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/112—Phosphorus-containing compounds, e.g. phosphates, phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)

Abstract

Cette invention se rapporte à des ciments osseux anti-résorption, qui comprennent une quantité anti-résorption d'un ou plusieurs agents anti-résorption, cet agent étant constitué de préférence par un bisphosphonate. Ces ciments osseux anti-résorption servent à réduire les vides osseux et à fixer des prothèses à l'os. Cette invention se rapporte également à des implants osseux allogènes, autogreffés et xénogreffés, qui contiennent une quantité anti-résorption d'un agent anti-résorption, tel qu'un bisphophonate. Ces greffes osseuses anti-résorption sont utiles pour la chirurgie osseuse reconstructive.
CA002360319A 1999-02-09 2000-02-09 Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes Abandoned CA2360319A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11926099P 1999-02-09 1999-02-09
US60/119,260 1999-02-09
PCT/US2000/003285 WO2000047214A1 (fr) 1999-02-09 2000-02-09 Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes

Publications (1)

Publication Number Publication Date
CA2360319A1 true CA2360319A1 (fr) 2000-08-17

Family

ID=22383420

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002360319A Abandoned CA2360319A1 (fr) 1999-02-09 2000-02-09 Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes

Country Status (5)

Country Link
EP (1) EP1150684A4 (fr)
JP (1) JP2002536123A (fr)
AU (1) AU776555B2 (fr)
CA (1) CA2360319A1 (fr)
WO (1) WO2000047214A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413535B1 (en) 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6632447B1 (en) 1998-05-07 2003-10-14 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
WO2002080933A1 (fr) * 2001-04-03 2002-10-17 The Royal Alexandra Hospital For Children Medicament a utiliser en matiere de greffe osseuse
JP2005514972A (ja) * 2001-11-29 2005-05-26 ジェジュテク，キャシー 吸収が調節される骨インプラント
FR2836681B1 (fr) 2002-03-04 2004-06-18 Centre Nat Rech Scient Compose phosphocalcique modifie, composition injectable le contenant
IL153699A (en) 2002-12-26 2008-11-26 Prochon Biotech Ltd The composition for transplantation basically
GB0307834D0 (en) * 2003-04-04 2003-05-14 Ta Contrast Ab Composition
US9539367B2 (en) 2003-12-04 2017-01-10 University Of Iowa Research Foundation Gallium inhibits biofilm formation
WO2006123589A1 (fr) * 2005-05-16 2006-11-23 Tokyo Medical And Dental University Materiau destine a un usage medical
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
EP1958649A1 (fr) 2007-02-14 2008-08-20 Graftys Ciment calcium-phosphate injectable libérant un inhibiteur de la résorption osseuse
WO2009006921A1 (fr) * 2007-07-10 2009-01-15 Barrera Jose Bouza Substance microporeuse pour implant chirurgical
WO2009134856A2 (fr) * 2008-04-30 2009-11-05 Genta Incorporated Compositions pharmaceutiques à base de gallium et procédés associés
EP2228080A1 (fr) * 2009-03-03 2010-09-15 Graftys Biomatériaux de phosphate de calcium au gallium
WO2013043529A1 (fr) * 2011-09-19 2013-03-28 Emory University Activation de la voie de la protéine morphogénétique osseuse, compositions pour ossification et méthodes associées
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
DE102016209988A1 (de) * 2016-06-07 2017-12-07 Heraeus Medical Gmbh Pastenförmiger Zweikomponenten-Polymethylmethacrylat-Knochenzement
CN109010909A (zh) * 2018-09-05 2018-12-18 杭州市萧山区中医院 聚甲基丙烯酸甲酯复合红霉素骨水泥用于防治假体周围骨溶解和炎症反应的应用
CN109010334A (zh) * 2018-09-05 2018-12-18 杭州市萧山区中医院 聚甲基丙烯酸甲酯复合辛伐他汀骨水泥用于制备假体周围骨溶解和炎症反应的药物中的应用
CN111321403B (zh) * 2020-03-10 2022-03-11 河北北方学院 一种基于多巴胺的锌表面载镓-氧化石墨烯复合涂层的制备方法
CN113181425A (zh) * 2021-04-28 2021-07-30 北京邦塞科技有限公司 骨水泥固相粉料、骨水泥及其制备方法和应用
CN114984310B (zh) * 2022-06-30 2023-09-08 西安理工大学 一种抗溃散吸水膨胀有机-无机复合骨水泥及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92465C (fi) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
EP0831756A1 (fr) * 1995-06-06 1998-04-01 Merck & Co., Inc. Composition a base de ciment de bisphosphonate permettant d'eviter le relachement aseptique des protheses orthopediques
EP0851772A1 (fr) * 1995-06-06 1998-07-08 Gensci Regeneration Laboratories, Inc. Materiaux osteogeniques modifies
US6010711A (en) * 1996-01-26 2000-01-04 University Of Rochester Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors

Also Published As

Publication number Publication date
AU3358800A (en) 2000-08-29
EP1150684A4 (fr) 2005-06-15
WO2000047214A1 (fr) 2000-08-17
JP2002536123A (ja) 2002-10-29
AU776555B2 (en) 2004-09-16
WO2000047214A9 (fr) 2002-04-11
EP1150684A1 (fr) 2001-11-07

Similar Documents

Publication Publication Date Title
AU776555B2 (en) Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
US20080286377A1 (en) Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
Fosca et al. Factors influencing the drug release from calcium phosphate cements
Bai et al. 3D printed porous biomimetic composition sustained release zoledronate to promote osteointegration of osteoporotic defects
JP4975934B2 (ja) 注射可能な骨鉱物置換材料
Temenoff et al. Injectable biodegradable materials for orthopedic tissue engineering
KR101520114B1 (ko) 스트론튬 화합물을 함유하는 섬유소 조성물
CN101264340B (zh) 用于填充骨缺损的陶瓷组合物
US6355705B1 (en) Anaesthetic bone cement
Park et al. Calcium phosphate combination biomaterials as human mesenchymal stem cell delivery vehicles for bone repair
Wang et al. Assessing the character of the rhBMP-2-and vancomycin-loaded calcium sulphate composites in vitro and in vivo
JP5770689B2 (ja) 骨セメントを製造するためのキットおよび方法
US10682442B2 (en) Small molecule drug release from in situ forming degradable scaffolds incorporating hydrogels and bioceramic microparticles
KR20100026910A (ko) 서방형 골다공증치료제를 담지한 골충진재
US7887831B2 (en) Bone enhancing composite
US20220287972A1 (en) Treatment approach by targeted delivery of bioactive molecules
KR102247732B1 (ko) 골 보강용 아크릴 시멘트
Young et al. Release, biological potency, and biochemical integrity of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) combined with AugmentTM Bone Graft or GEM 21S beta-tricalcium phosphate (β-TCP)
CN1446589A (zh) 药物控释功能磷酸钙骨水泥及其在临床上的应用
US20220023493A1 (en) Compositions and methods for regeneration of bone tissue
Lu et al. Histological and biomechanical studies of two bone colonizable cements in rabbits
Goto et al. The biocompatibility and osteoconductivity of a cement containing β–TCP for use in vertebroplasty
Luginbuehl et al. Controlled release of tetracycline from biodegradable β‐tricalcium phosphate composites
EP2967799B1 (fr) Systèmes et procédés d'utilisation d'antibiotiques liés de façon chimique activés par des infections
US20100178250A1 (en) Method of Local Delivery of Bioactive and Diagnostic Agents Using Magnetizable Bone Cement

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20100209